VEGFR-2-IN-5 T2056
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
UNC0064-12 is a patent compound in WO2013055780A1, multikinase inhibitor and has a -NH2 terminal linker for further synthesis.
CAS nr:
1430089-64-7
Purity:
98%
Molecular Weight:
364,45
SMILES:
NCCCNc1ccc(Nc2nccc(Nc3n[nH]c(c3)C3CC3)n2)cc1
Formula:
C19H24N8
Pathway:
Tyrosine Kinase/Adaptors,Angiogenesis
Target:
VEGFR,VEGFR
At Solulink, we develop high-performance products that link biomolecules together. Our continuous efforts in new product development and service offerings enable you to remain at the forefront of advanced bioscience research. The Company’s proprietary HyNic/4FB chemistry is unique among bioconjugation methods in combining superb stability with high specificity and versatility, suitable for conjugation of all classes of biomolecules, including peptides, proteins, oligonucleotides, and carbohydrates, with all types of labels, including fluorophores, chromogenic moieties, surfaces, and small molecules. HyNic/4FB chemistry underlies the majority of Solulink’s extensive product catalog, comprised of various kits and tools that enable efficient and stable antibody, bead, and oligonucleotide labeling.